Screening for Latent Tuberculosis Infection in Adults
Author(s) -
Kirsten BibbinsDomingo,
David C. Grossman,
Susan J. Curry,
L.M. Bauman,
Karina W. Davidson,
John W. Epling,
Francisco García,
Jessica Herzstein,
Alex R. Kemper,
Alex H. Krist,
Ann Kurth,
C. Seth Landefeld,
Carol M. Mangione,
William R. Phillips,
Maureen G. Phipps,
Michael Pig
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.11046
Subject(s) - medicine , latent tuberculosis , asymptomatic , disease , active tuberculosis , tuberculosis , intensive care medicine , mycobacterium tuberculosis , pathology
Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom